Details of the Metabolic Reaction (MR)
| General Information of This Metabolic Reaction (MR) (ID: MR004670) | ||||||
|---|---|---|---|---|---|---|
| Formula | ||||||
| Reactant | Imatinib mesylate | Product | AFN911 | |||
| Reactant Info | Product Info | |||||
| Metabolic Enzyme | Cytochrome P450 3A4 (CYP3A4) | DME Info | ||||
| Cytochrome P450 1A1 (CYP1A1) | DME Info | |||||
| Cytochrome P450 1B1 (CYP1B1) | DME Info | |||||
| Leukotriene B4 omega-hydroxylase (CYP4F3) | DME Info | |||||
| Metabolic Type | Oxidation - Benzyl hydroxylation | |||||
| References | ||||||
|---|---|---|---|---|---|---|
| 1 | Metabolism and disposition of imatinib mesylate in healthy volunteers | |||||
| 2 | In vitro biotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1 | |||||
| 3 | Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. | |||||
| 4 | Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.



